🟢 Achieve Life Sciences is trading 6.17% up in pre-market

Achieve Life Sciences is trading at $7.40, up 6.17% in pre-market; no clear company-specific catalyst has been identified.

• The company’s news page shows no October 16 announcement; its latest listed releases are dated October 7 and October 6.
• Achieve Life Sciences previously announced a presentation of 52-week cytisinicline data at CHEST 2026, scheduled for October 18–21; that announcement does not establish the cause of the move.
• No direct connection to broader market conditions was identified, and pre-market volume information is unavailable.